Stock EDGE THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Edge Therapeutics Inc Nasdaq

Equities

US2798701098

Chart calendar Edge Therapeutics Inc

ca79d07d156669de.TwxhG0gpVNRBp_kNUqQAVy2mS1ycOdfWB2qJvUNl0W8.FlkLKgt6ZaEx6o1fGv51MUD1KCXeT-GyRlLNizoM6TcYSgBQEh0t5w_Rng~e15b7eb41043510ccc5602af2fb20032

Upcoming events on Edge Therapeutics Inc

21/05/2024 15:00 A.G.P.’s Virtual Healthcare Company Showcase
13/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Edge Therapeutics Inc

Today Q1 2024 Earnings Release Pre-market
13/05/2024 17:30 Citizens JMP Life Sciences Conference
08/05/2024 18:30 Investor Meeting - Key Opinion Leader
27/03/2024 12:00 Q4 2023 Earnings Call
27/03/2024 11:30 Q4 2023 Earnings Release
18/01/2024 15:00 B. Riley Securities Oncology Conference
04/12/2023 Noble Capital Markets Emerging Growth Equity Conference
14/11/2023 13:00 Q3 2023 Earnings Call
14/11/2023 12:30 Q3 2023 Earnings Release
19/10/2023 European Society for Medical Oncology Congress - Abstract Number : 6982
18/10/2023 08:00 International Cytokine and Interferon Society Meeting - Ravi A. Madan
04/10/2023 19:00 LD Micro Main Conference
04/10/2023 19:00 LD Micro Main Conference
03/10/2023 13:00 Investor Meeting - Key Opinion Leader
01/10/2023 16:00 American Society for Radiation Oncology Meeting - Abstract Number #: 55593
26/09/2023 19:45 Cantor Global Healthcare Conference - Panel
19/09/2023 13:10 European Scientific Working Group on Influenza Conference - James Allen
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
14/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 12:30 Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-20,9
-20,4
-2.63%		-14,9
-15,0
0.67%		-21,4
-22,4
4.14%		-41,7
-31,2
-33.46%		-43,0
-44,2
2.74%
-51,0

EBIT
Million USD		Released
Forecast
Spread 		-21,0
-20,4
-3.11%		-14,9
-14,9
0.28%		-21,4
-22,0
2.58%		-41,7
-30,9
-35.01%		-43,0
-44,9
4.16%
-50,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-14,8
-15,0
1.09%		-21,4
-22,4
4.32%		-42,1
-31,4
-34.09%		-44,3
-46,3
4.19%
-49,4

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-14,8
-14,9
0.09%		-16,9
-19,3
12.36%		-40,9
-30,3
-35%		-42,9
-44,8
4.08%
-49,4

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-0,89
-0,84
-6.59%		-0,66
-0,71
6.6%		-1,43
-1,08
-32.06%		-1,39
-1,45
4.23%
-1,51

Announcement Date27/03/2018/03/2131/03/2228/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread 		-6,32
-7,25
12.82%		-8,48
-6,15
-37.87%		-7,09
-9,00
21.19%		-7,28
-8,15
10.68%		-18,8
-8,40
-124.06%		-9,42
-8,30
-13.49%		-12,7
-8,70
-45.88%		-10,5
-13,9
24.35%		-10,4
-13,1
20.36%
-11,1


-12,5


-13,3


-14,1

EBIT
Million USD		Released
Forecast
Spread 		-6,32
-8,44
25.1%		-8,48
-6,56
-29.21%		-7,09
-8,38
15.36%		-7,28
-8,14
10.53%		-18,8
-8,01
-135.04%		-9,42
-9,16
-2.81%		-12,7
-10,2
-24.62%		-10,5
-14,0
24.98%		-10,4
-12,4
16.29%
-11,4


-11,2


-11,8


-12,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,32
-7,30
13.42%		-8,47
-7,05
-20.2%		-7,02
-8,70
19.33%		-7,42
-8,41
11.75%		-19,1
-8,43
-126.92%		-9,66
-9,05
-6.74%		-12,9
-10,1
-27.92%		-10,8
-14,3
24.13%		-10,9
-12,9
15.19%
-11,6


-12,0


-12,7


-13,1

Net income
Million USD		Released
Forecast
Spread 		-6,32
-6,90
8.4%		-8,47
-6,56
-29.13%		-5,82
-7,46
22%		-7,42
-8,21
9.53%		-19,1
-8,54
-124.22%		-9,66
-9,39
-2.84%		-11,5
-10,5
-9.88%		-10,8
-14,6
25.78%		-10,9
-12,7
14.41%
-11,6


-11,5


-12,7


-13,6

EPS
USD		Released
Forecast
Spread 		-0,23
-0,24
4.83%		-0,32
-0,23
-36.75%		-0,20
-0,28
28.99%		-0,26
-0,28
7.61%		-0,67
-0,29
-133.34%		-0,32
-0,31
-4.67%		-0,37
-0,34
-8.82%		-0,35
-0,45
21.47%		-0,35
-0,41
14.63%
-0,36


-0,36


-0,37


-0,37

Announcement Date31/03/2211/05/2208/08/2214/11/2228/03/2315/05/2314/08/2314/11/2327/03/24----

Upcoming sector events for Edge Therapeutics Inc

15/05/2024 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 14:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Edge Therapeutics Inc

Today CELCUITY INC.: Q1 2024 Earnings Release
13/05/2024 IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
13/05/2024 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
13/05/2024 NYKODE THERAPEUTICS: Q1 2024 Earnings Release
13/05/2024 ABL BIO INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 21:01 ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024 PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024 INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. PDSB Stock
  4. Stock
  5. Calendar Edge Therapeutics Inc